We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-41%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$147M
AUM Growth
-$523M
Cap. Flow
-$201M
Cap. Flow %
-136.49%
Top 10 Hldgs %
64.77%
Holding
167
New
23
Increased
38
Reduced
54
Closed
36

Top Buys

Rank Stock Value
1
GEVO icon
Gevo
GEVO
+$20.1M
2
DOGZ icon
Dogness International Corp
DOGZ
+$8.37M
3
ONCO icon
Onconetix
ONCO
+$5.5M
4
MMAT
Meta Materials Inc. Common Stock
MMAT
+$3.83M
5
NEPT
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
+$3.81M

Top Sells

Rank Stock Value
1
CNTX icon
Context Therapeutics
CNTX
+$2.53M
2
HMCO
HumanCo Acquisition Corp. Class A Common Stock
HMCO
+$1.42M
3
USWS
U.S. Well Services, Inc. Class A Common Stock
USWS
+$1.07M
4
GYRE icon
Gyre Therapeutics
GYRE
+$871K
5
AGMH icon
AGM Group Holdings
AGMH
+$859K

Sector Composition

Rank Sector Weight
1 Healthcare 12.65%
2 Materials 8.79%
3 Technology 5.39%
4 Consumer Discretionary 3.75%
5 Consumer Staples 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FEED
126
ENvue Medical Inc
FEED
$1.95M
$6K ﹤0.01%
5
– –
GROMW
127
DELISTED
Grom Social Enterprises Inc. Warrants
GROMW
$1K ﹤0.01%
425
– –
ADTX
128
DELISTED
ADITXT INC
ADTX
– –
0
– -$264K
ADTX
129
PUT
DELISTED
ADITXT INC
ADTX
– –
0
– -$86K
BKYI
130
BIO-key International
BKYI
$4.7M
– –
-243
Closed -$105K
BKYI
131
PUT
BIO-key International
BKYI
$4.7M
– –
-6
Closed -$253K
CNTX icon
132
Context Therapeutics
CNTX
$55.8M
– –
-1,165,100
Closed -$2.53M
ESPR
133
CALL
DELISTED
Esperion Therapeutics
ESPR
– –
-100
Closed -$46K
FLUX icon
134
Flux Power
FLUX
$11.5M
– –
-77,833
Closed -$208K
GYRE icon
135
Gyre Therapeutics
GYRE
$648M
– –
-176,000
Closed -$871K
IKT icon
136
Inhibikase Therapeutics
IKT
$358M
– –
-16,500
Closed -$147K
IMPP icon
137
Imperial Petroleum
IMPP
$212M
– –
-5,764
Closed -$69.1K
MODD icon
138
Modular Medical
MODD
$11.2M
– –
-1,010
Closed -$133K
MTC icon
139
MMTec
MTC
$391M
– –
-2,308
Closed -$114K
NCTY
140
PUT
The9 Ltd
NCTY
$69.5M
– –
-65
Closed -$194K
NRXP icon
141
PUT
NRX Pharmaceuticals
NRXP
$134M
– –
-181
Closed -$444K
OEF icon
142
CALL
iShares S&P 100 ETF
OEF
$19.9B
– –
-3,076
Closed -$63.1M
PPBT
143
Purple Biotech
PPBT
$1.28M
– –
-133
Closed -$105K
PPBT
144
PUT
Purple Biotech
PPBT
$1.28M
– –
-2
Closed -$138K
REW icon
145
PUT
Proshares UltraShort Technology
REW
$3.44M
– –
-121
Closed -$2.75M
SPY icon
146
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$784B
– –
-2,214
Closed -$100M
CHAI
147
Core AI Holdings Inc
CHAI
$9.3M
– –
0
– -$13K
VXX icon
148
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$158M
– –
-262
Closed -$10.8M
IMG
149
PUT
DELISTED
CIMG Inc
IMG
– –
0
– -$42K
ALPP
150
PUT
DELISTED
Alpine 4 Holdings Inc
ALPP
– –
-92
Closed -$77K
3 4 5
6
7

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AB
Aozora Bank Tokyo, Japan $43.6M AUM 1.15% 1-Year Est. Return

Sabby Management's Q2 2022 Portfolio in Review

As of Q2 2022, Sabby Management held 167 positions worth $147M, down 78% from $670M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Sabby Management withdrew a net $201M in Q2 2022, closing 36 positions and reducing 54 holdings. Its most notable exit was Context Therapeutics, an estimated $2.53M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 7.6% a quarter earlier, followed by Materials and Technology.

Against the trend, Sabby Management opened a new position in Gevo worth $12.9M.

  • Sabby Management's largest Q2 2022 buy was Gevo: 5,486,831 shares worth $12.9M.
  • Sabby Management added most to Canaan Creative in Q2 2022, an estimated $1.46M increase.
  • Sabby Management's biggest Q2 2022 reduction was HumanCo Acquisition Corp. Class A Common Stock, cutting an estimated $1.42M.
  • Sabby Management fully exited Context Therapeutics in Q2 2022, selling an estimated $2.53M.
  • Sabby Management's ten largest holdings make up 65% of its $147M portfolio in Q2 2022.
  • Sabby Management opened 23 new positions and closed 36 in Q2 2022.
  • Sabby Management's portfolio value fell 78% quarter-over-quarter to $147M.

Based on Sabby Management's 13F filing for Q2 2022, filed 15 Aug 2022.